SEC Form 4 · insider transactions · free
GILEAD SCIENCES, INC. insider buying and selling
18 Form 4 filings against GILEAD SCIENCES, INC. (GILD) in the last 90 days. Below are the transactions from 4 recent filings, one per insider where the window allows, as filed.
| Date | Insider | Role | Transaction | Code | Shares | Price | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | O'Day Daniel Patrick | Chairman & CEO, director | open-market sale | S | 12,000 | $147.72 | 569,683 |
| 2026-10-01 | O'Day Daniel Patrick | Chairman & CEO, director | open-market sale | S | 3,000 | $148.63 | 566,683 |
| 2026-09-22 | Burkhart Erin | SVP, Controllership | option exercise | M | 2,223 | 2,223 | |
| 2026-09-22 | Burkhart Erin | SVP, Controllership | tax withholding | F | 768 | $152.67 | 1,455 |
| 2026-09-15 | Mercier Johanna | Chief Comm & Corp Aff Officer | open-market sale | S | 1,600 | $143.69 | 118,084 |
| 2026-09-15 | Mercier Johanna | Chief Comm & Corp Aff Officer | open-market sale | S | 800 | $144.46 | 117,284 |
| 2026-09-15 | Mercier Johanna | Chief Comm & Corp Aff Officer | open-market sale | S | 600 | $145.29 | 116,684 |
| 2026-09-15 | Dickinson Andrew D | Chief Financial Officer | open-market sale | S | 3,000 | $145.29 | 164,096 |
The Form 4 flow against GILEAD SCIENCES, INC., parsed and explained
The free view above is the newest few filings. The paid report reads the newest Form 4 filings of the last 90 days (up to 100), separates open-market buys and sales from awards, exercises and tax withholding, totals the flow per insider, flags 10b5-1 plans where the filing notes them, and hands you a cited write-up plus a downloadable transactions table.
agents: POST /v1/insider-report with {"ticker":"GILD"} over x402 or MPP, $0.60
Generated from public SEC EDGAR filings. Filing data is shown as filed. This is information, not investment advice.